Skip to main content

Table 1 Summary of SEARCH cohort

From: Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier

  

HGSOC

LGSOC

MOC

EOC

CCOC

Others

Number of patients

245

35

50

97

62

27

Age at diagnosis (years)

57 (8.2)

53.9 (11.8)

53.4 (12.4)

54.5 (9.4)

55.8 (7.4)

56.2 (9)

Entry time (months)

23.5 (18.9 to 32.1)

26.4 (19.6 to 33.5)

28 (18.2 to 47.6)

28.7 (21.2 to 46.4)

29.4 (19.4 to 59.6)

27.8 (23.1 to 31.6)

Last follow-up time (months)

71.1 (45.4 to 105.6)

126.5 (85.7 to 149.1)

123 (83.1 to 170.3)

140.9 (86.5 to 171.2)

144.8 (101.6 to 208.2)

97.8 (73.7 to 139.7)

Vital status

Data available

245 (100%)

35 (100%)

50 (100%)

97 (100%)

62 (100%)

27 (100%)

 

Alive

89 (36%)

27 (77%)

39 (78%)

69 (71%)

47 (76%)

16 (59%)

 

Died

156 (64%)

8 (23%)

11 (22%)

28 (29%)

15 (24%)

11 (41%)

Stage

Data available

238 (97%)

33 (94%)

47 (94%)

96 (99%)

62 (100%)

24 (89%)

 

I

46 (19%)

27 (82%)

42 (89%)

76 (79%)

50 (81%)

13 (54%)

 

II

27 (11%)

2 (6%)

1 (2%)

13 (14%)

6 (10%)

5 (21%)

 

III

139 (58%)

4 (12%)

4 (9%)

6 (6%)

5 (8%)

5 (21%)

 

IV

26 (11%)

0 (0%)

0 (0%)

1 (1%)

1 (2%)

1 (4%)

Grade

Data available

201 (82%)

13 (37%)

26 (52%)

78 (80%)

26 (42%)

11 (41%)

 

I

1 (0%)

11 (85%)

10 (38%)

22 (28%)

2 (8%)

1 (9%)

 

II

56 (28%)

1 (8%)

14 (54%)

40 (51%)

11 (42%)

7 (64%)

 

III

144 (72%)

1 (8%)

2 (8%)

16 (21%)

13 (50%)

3 (27%)

PTEN status (IF)

Data available

214 (87%)

29 (83%)

41 (82%)

89 (92%)

59 (95%)

26 (96%)

 

Negative

49 (23%)

2 (7%)

12 (29%)

39 (44%)

34 (58%)

8 (31%)

 

Weak positive

68 (32%)

6 (21%)

11 (27%)

27 (30%)

18 (31%)

8 (31%)

 

Heterogeneous

48 (22%)

7 (24%)

2 (5%)

3 (3%)

1 (2%)

3 (12%)

 

Positive

49 (23%)

14 (48%)

16 (39%)

20 (22%)

6 (10%)

7 (27%)

PTEN status (IHC)

Data available

211 (86%)

28 (80%)

44 (88%)

90 (93%)

56 (90%)

26 (96%)

 

Negative

53 (25%)

3 (11%)

9 (20%)

35 (39%)

22 (39%)

4 (15%)

 

Weak positive

73 (35%)

8 (29%)

5 (11%)

28 (31%)

18 (32%)

5 (19%)

 

Heterogeneous

34 (16%)

3 (11%)

6 (14%)

6 (7%)

3 (5%)

3 (12%)

 

Positive

51 (24%)

14 (50%)

24 (55%)

21 (23%)

13 (23%)

14 (54%)

  1. Data are mean (SD), median (OQR), n (%) or n.
  2. CCOC, clear cell ovarian cancer; EOC, endometrial ovarian cancer; HGSOC, high-grade serous ovarian cancer; IF, immunofluorescence; IHC, immunohistochemistry; LGSOC, low-grade serous ovarian cancer; MOC, mucinous ovarian cancer.